Pharmaceutical Industry Information Portal

HomeNews

News

RDIF and Serum Institute of India to start production of Sputnik vaccine in September

The first batch of Sputnik vaccine is expected to be produced at SII’s facilities in September. The parties intend to produce over 300 million doses of the vaccine in India per year.

R-Pharm and Frontier Biotech will provide Russia with a new drug for the treatment of HIV

Aikening™ is a new fusion inhibitor. It is the first and only long-acting injectable (as IV infusion QW) available as a dual therapy for treatment-experienced patients with HIV-1 replication.

Sputnik V vaccine effective against new variants of coronavirus

Sputnik V pioneered the vaccine cocktail approach with two shots. The tests conducted by the Gamaleya Center have demonstrated validity of this approach.

SINOVAC Enters Into Agreement to Supply CoronaVac® to COVAX

In total, up to 380 million doses of CoronaVac® will be available to both self-financing participants of the Facility as well as those supported by the Gavi COVAX AMC.

Media allegations on the rise in medicine prices are manipulative

To date, the FAS Russia has already set 61 new economically reasonable prices for 22 medicines, ensuring their presence in the market.

European Pharmacopoeia to put an end to the rabbit pyrogen test

There are currently 59 Ph. Eur. texts – covering a variety of topics including vaccines for human use, blood products, antibiotics, radiopharmaceuticals and containers – that refer to the RPT and will be affected.
spot_img

Expert Articles

spot_img